TV TPI

TPI (Targeted Protein Inhibition) is a biotechnology company focused on developing a novel class of therapeutics that leverage the body's natural protein degradation pathways. The company's platform is designed to target and eliminate disease-causing proteins that were previously considered undruggable by traditional small molecule inhibitors. By utilizing advanced medicinal chemistry and structural biology, TPI aims to create highly selective degraders for applications in oncology and inflammatory diseases. The company is currently advancing several programs through the pre-clinical stage to validate its approach in high-unmet-need indications.